0OT.SG - Ocular Therapeutix Inc

Stuttgart - Stuttgart Delayed price. Currency in EUR
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
51,494
51,494
43,522
17,403
4,227
Cost of revenue
4,540
4,540
4,406
2,083
2,325
Gross profit
46,954
46,954
39,116
15,320
1,902
Operating expenses
Research development
53,462
53,462
50,083
28,694
41,091
Selling general and administrative
72,146
72,146
67,070
49,473
46,613
Total operating expenses
125,608
125,608
117,153
78,167
87,704
Operating income or loss
-78,654
-78,654
-78,037
-62,847
-85,802
Interest expense
7,022
7,022
6,671
6,768
6,101
Total other income/expenses net
13,840
13,840
78,122
-86,189
4,302
Income before tax
-71,038
-71,038
-6,553
-155,636
-86,372
Income from continuing operations
-71,038
-71,038
-6,553
-155,636
-86,372
Net income
-71,038
-71,038
-6,553
-155,636
-86,372
Net income available to common shareholders
-71,038
-71,038
-6,553
-155,636
-86,372
Basic EPS
-
-
-0.09
-2.56
-1.91
Diluted EPS
-
-
-0.98
-2.56
-1.91
Basic average shares
-
-
76,393
60,752
45,273
Diluted average shares
-
-
82,162
60,752
45,273
EBITDA
-
-64,016
118
-148,868
-80,271